Irinotecan plus raltitrexed as second-line treatment in locally advanced or metastatic colorectal cancer patients: a prospective open-label, single-arm, multi-center, phase II study
伊立替康联合雷替曲塞作为局部晚期或转移性结直肠癌患者二线治疗:一项前瞻性、开放标签、单臂、多中心 II 期研究
期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-024-12831-4
Cheng, Yu; Teng, Zan; Zhang, Yanqiao; Jin, Bo; Zheng, Zhendong; Man, Li; Wang, Zhenghua; Teng, Yuee; Yu, Ping; Shi, Jing; Luo, Ying; Wang, Ying; Zhang, Jingdong; Zhang, Huijuan; Liu, Jiwei; Chen, Hao; Xiao, Jiawen; Zhao, Lei; Zhang, Lingyun; Jiang, Yu; Chen, Ying; Zhang, Jian; Wang, Chang; Liu, Sa; Qu, Jinglei; Qu, Xiujuan; Liu, Yunpeng